Victoria Ameral to Humans
This is a "connection" page, showing publications Victoria Ameral has written about Humans.
Connection Strength
0.197
-
Ameral V, Hocking E, Leviyah X, Newberger NG, Timko C, Livingston N. Innovating for real-world care: A systematic review of interventions to improve post-detoxification outcomes for opioid use disorder. Drug Alcohol Depend. 2022 04 01; 233:109379.
Score: 0.030
-
Ameral V, Palm Reed KM. Envisioning a future: Values clarification in early recovery from opioid use disorder. J Subst Abuse Treat. 2021 02; 121:108207.
Score: 0.028
-
Palm Reed KM, Cameron AY, Ameral VE. A Contextual Behavior Science Framework for Understanding How Behavioral Flexibility Relates to Anxiety. Behav Modif. 2018 11; 42(6):914-931.
Score: 0.022
-
Ameral V, Palm Reed KM, Hines DA. An Analysis of Help-Seeking Patterns Among College Student Victims of Sexual Assault, Dating Violence, and Stalking. J Interpers Violence. 2020 11; 35(23-24):5311-5335.
Score: 0.022
-
DeVito EE, Ameral V, Sofuoglu M. Sex differences in comorbid pain and opioid use disorder: A scoping review. Br J Clin Pharmacol. 2024 Dec; 90(12):3067-3083.
Score: 0.009
-
Livingston N, Ameral V, Hocking E, Leviyah X, Timko C. Interventions to Improve Post-Detoxification Treatment Engagement and Alcohol Recovery: Systematic Review of Intervention Types and Effectiveness. Alcohol Alcohol. 2022 Jan 08; 57(1):136-150.
Score: 0.008
-
Shirk SD, Ameral V, Kraus SW, Houchins J, Kelly M, Pugh K, Reilly E, Desai N. Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A?Retrospective Chart Review. J Dual Diagn. 2021 Jul-Sep; 17(3):207-215.
Score: 0.007
-
Livingston NA, Simpson T, Lehavot K, Ameral V, Brief DJ, Enggasser J, Litwack S, Helmuth E, Roy M, Rosenbloom D, Keane TM. Differential alcohol treatment response by gender following use of VetChange. Drug Alcohol Depend. 2021 04 01; 221:108552.
Score: 0.007
-
Enggasser JL, Livingston NA, Ameral V, Brief DJ, Rubin A, Helmuth E, Roy M, Solhan M, Litwack S, Rosenbloom D, Keane TM. Public implementation of a web-based program for veterans with risky alcohol use and PTSD: A RE-AIM evaluation of VetChange. J Subst Abuse Treat. 2021 03; 122:108242.
Score: 0.007
-
Livingston NA, Ameral V, Banducci AN, Weisberg RB. Unprecedented need and recommendations for harnessing data to guide future policy and practice for opioid use disorder treatment following COVID-19. J Subst Abuse Treat. 2021 03; 122:108222.
Score: 0.007
-
Livingston NA, Mahoney CT, Ameral V, Brief D, Rubin A, Enggasser J, Litwack S, Helmuth E, Roy M, Solhan M, Rosenbloom D, Keane T. Changes in alcohol use, PTSD hyperarousal symptoms, and intervention dropout following veterans' use of VetChange. Addict Behav. 2020 08; 107:106401.
Score: 0.007
-
Bishop LS, Ameral VE, Palm Reed KM. The Impact of Experiential Avoidance and Event Centrality in Trauma-Related Rumination and Posttraumatic Stress. Behav Modif. 2018 11; 42(6):815-837.
Score: 0.006
-
Ollen EW, Ameral VE, Palm Reed K, Hines DA. Sexual minority college students' perceptions on dating violence and sexual assault. J Couns Psychol. 2017 Jan; 64(1):112-119.
Score: 0.005
-
Nyer M, Holt DJ, Pedrelli P, Fava M, Ameral V, Cassiello CF, Nock MK, Ross M, Hutchinson D, Farabaugh A. Factors that distinguish college students with depressive symptoms with and without suicidal thoughts. Ann Clin Psychiatry. 2013 Feb; 25(1):41-9.
Score: 0.004
-
Mischoulon D, Brill CD, Ameral VE, Fava M, Yeung AS. A pilot study of acupuncture monotherapy in patients with major depressive disorder. J Affect Disord. 2012 Dec 10; 141(2-3):469-73.
Score: 0.004
-
Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry. 2011 Dec; 72(12):1660-8.
Score: 0.004
-
Bitran S, Farabaugh AH, Ameral VE, LaRocca RA, Clain AJ, Fava M, Mischoulon D. Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI. Int Clin Psychopharmacol. 2011 Jul; 26(4):206-12.
Score: 0.004
-
Iovieno N, Tedeschini E, Levkovitz Y, Ameral VE, Papakostas GI. Does the frequency of follow-up assessments affect clinical trial outcome? A meta-analysis and meta-regression of placebo-controlled randomized trials. Int J Neuropsychopharmacol. 2012 Apr; 15(3):289-96.
Score: 0.004
-
Iovieno N, Tedeschini E, Ameral VE, Rigatelli M, Papakostas GI. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials. Int Clin Psychopharmacol. 2011 Mar; 26(2):69-74.
Score: 0.004
-
Yeung AS, Ameral VE, Chuzi SE, Fava M, Mischoulon D. A pilot study of acupuncture augmentation therapy in antidepressant partial and non-responders with major depressive disorder. J Affect Disord. 2011 Apr; 130(1-2):285-9.
Score: 0.003
-
Papakostas GI, Clain A, Ameral VE, Baer L, Brintz C, Smith WT, Londborg PD, Glaudin V, Painter JR, Fava M. Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. Int Clin Psychopharmacol. 2010 Jan; 25(1):17-21.
Score: 0.003
-
Sanders LD, Ameral V, Sayles K. Event-related potentials index segmentation of nonsense sounds. Neuropsychologia. 2009 Mar; 47(4):1183-6.
Score: 0.003